William G. Kaelin Jr., born on November 23, 1957, is a distinguished American physician-scientist renowned for his groundbreaking contributions to the field of oncology. As a professor of medicine at Harvard University and the Dana–Farber Cancer Institute, he leads a laboratory dedicated to the study of tumor suppressor proteins, which play a crucial role in cancer research.
Throughout his illustrious career, Kaelin has been honored with numerous prestigious awards, including the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. His work has significantly advanced our understanding of cellular mechanisms, particularly in how cells sense and adapt to oxygen availability.
In 2019, Kaelin was awarded the Nobel Prize in Physiology or Medicine, sharing this esteemed recognition with Peter J. Ratcliffe and Gregg L. Semenza. Their collaborative research has provided vital insights into the intricate processes that govern cellular responses to oxygen levels, marking a pivotal moment in medical science.